- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Eli Lilly and Company's top products based on revenue 2014-2018
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Eli Lilly and Company's top products based on revenue 2014-2018
Eli Lilly and Company's top products based on revenue from 2014 to 2018 (in million U.S. dollars)
by Matej Mikulic,
last edited
Aug 12, 2019
In 2018, Eli Lilly generated significant revenue from their top products. At that time Trulicity was their biggest revenue generator with about 3.2 billion U.S. dollars in sales. The next highest revenue generating drug in 2018 was Humalog with about 3 billion U.S. dollars in sales. Eli Lilly is a multi-national pharmaceutical company that is headquartered in Indianapolis, Indiana.
Eli Lilly Company
Eli Lilly was founded in 1876 in the United States. As of today, the company has almost 37 thousand employees globally. The company specializes in global health initiatives, diabetes care and a multitude of other products concerning human health. Eli Lilly currently markets products in over 120 countries globally. As of 2017, the company was among the top pharmaceutical companies based on both prescription sales and research and development spending.Diabetes products by Eli Lilly
Eli Lilly is the manufacturer of several of the global top diabetic pharmaceutical products and treatments. As of 2017, Eli Lilly was the second top seller of anti-diabetic pharmaceuticals based on revenue alone. Globally, Trulicity, one of Eli Lilly’s top drugs used in the treatment of type II diabetes, is projected to be the top anti-diabetic pharmaceutical by the year 2024. Among all pharmaceutical products in the U.S., Trulicity is expected to be among the top 10 pharmaceuticals based on sales in 2024.Eli Lilly and Company's top products based on revenue from 2014 to 2018 (in million U.S. dollars)
| 2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| 2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Aug 12, 2019
In 2018, Eli Lilly generated significant revenue from their top products. At that time Trulicity was their biggest revenue generator with about 3.2 billion U.S. dollars in sales. The next highest revenue generating drug in 2018 was Humalog with about 3 billion U.S. dollars in sales. Eli Lilly is a multi-national pharmaceutical company that is headquartered in Indianapolis, Indiana.
Eli Lilly Company
Eli Lilly was founded in 1876 in the United States. As of today, the company has almost 37 thousand employees globally. The company specializes in global health initiatives, diabetes care and a multitude of other products concerning human health. Eli Lilly currently markets products in over 120 countries globally. As of 2017, the company was among the top pharmaceutical companies based on both prescription sales and research and development spending.Diabetes products by Eli Lilly
Eli Lilly is the manufacturer of several of the global top diabetic pharmaceutical products and treatments. As of 2017, Eli Lilly was the second top seller of anti-diabetic pharmaceuticals based on revenue alone. Globally, Trulicity, one of Eli Lilly’s top drugs used in the treatment of type II diabetes, is projected to be the top anti-diabetic pharmaceutical by the year 2024. Among all pharmaceutical products in the U.S., Trulicity is expected to be among the top 10 pharmaceuticals based on sales in 2024.- Show sources information
- Show publisher information
- Release date
- February 2019
- Region
- Worldwide
- Survey time period
- 2011 to 2018
- Supplementary notes
- This statistic was assembled from several editions of Eli Lilly's annual report.
- Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- February 2019
More information
- Region
- Worldwide
- Survey time period
- 2011 to 2018
- Supplementary notes
- This statistic was assembled from several editions of Eli Lilly's annual report.
- Open this statistic in...
Other statistics on the topic
+Pharmaceutical Products & Market
Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
+Pharmaceutical Products & Market
Top 10 biotech and pharmaceutical companies based on market cap 2019
+Pharmaceutical Products & Market
Global anti-diabetic revenue by top ten pharmaceutical companies 2017 and 2024
+Pharmaceutical Products & Market
R&D spending share of top pharmaceutical companies 2018 and 2024
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Pharmaceutical brands: Cymbalta (Eli Lilly)
- 31 page/s
- English
- pptx
- Detailed references
Everything On "Pharmaceutical brands: Cymbalta (Eli Lilly)" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Eli Lilly"
- Global positioning
The most important statistics
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2019
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- Global top 10 companies based on biotech prescription drug market share in 2018 and 2024*Global biotech prescription drug market share - top 10 companies 2018 and 2024
- Top 10 pharmaceutical companies worldwide by number of originated drugs in 2019*Top pharma companies worldwide by number of originated drugs 2019
- Top 10 pharmaceutical companies by global anti-diabetic revenue in 2017 and 2024 (in million U.S. dollars)Global anti-diabetic revenue by top ten pharmaceutical companies 2017 and 2024
- Top 10 pharmaceutical companies based on R&D spending as revenue share in 2018 and 2024*R&D spending share of top pharmaceutical companies 2018 and 2024
- Revenue and income
The most important statistics
- Revenue of Eli Lilly and Company from 2007 to 2018 (in million U.S. dollars)Eli Lilly's total revenue 2007-2018
- Revenue of Eli Lilly and Company from 2014 to 2018, by segment (in million U.S. dollars)Eli Lilly's total revenue by segment 2014-2018
- Revenue of Eli Lilly and Company from 2014 to 2018, by region (in million U.S. dollars)*Eli Lilly's total revenue by region 2014-2018
- Eli Lilly and Company's top products based on revenue from 2014 to 2018 (in million U.S. dollars)Eli Lilly and Company's top products based on revenue 2014-2018
- Net income of Eli Lilly and Company from 2007 to 2018 (in million U.S. dollars)Eli Lilly's net income 2007-2018
- Eli Lilly's income before income taxes from 2013 to 2018 (in million U.S. dollars)Eli Lilly income before income taxes 2013-2018
- Expenses
The most important statistics
- Eli Lilly and Company's expenditure on research and development from 2007 to 2018 (in million U.S. dollars)Eli Lilly's research and development expenditure 2007-2018
- Eli Lilly's marketing, selling, and administrative expenses from 2013 to 2018 (in million U.S. dollars)Eli Lilly: marketing expenses 2013-2018
- Eli Lilly's capital expenditures from 2013 to 2018 (in million U.S. dollars)Eli Lilly capital expenditures 2013-2018
- Eli Lilly and Company advertising spending in the United States from 2012 to 2018 (in million U.S. dollars)Eli Lilly: ad spend in the U.S. 2012-2018
- Miscellaneous
The most important statistics
- Eli Lilly's number of employees from 2013 to 2018Eli Lilly employment numbers 2013-2018
- Revenue per employee of Eli Lilly and Company from 2013 to 2018 (in U.S. dollars)Eli Lilly's total revenue per employee 2013-2018
- Eli Lilly's total assets from 2013 to 2018 (in million U.S. dollars)Eli Lilly total assets 2013-2018
- Eli Lilly and Company's spending for research and development as a share of revenue from 2010 to 2018*Eli Lilly's R&D expenditure as a share of revenue 2010-2018
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Top specialty drug pharmacies in the U.S. by revenue 2018
- Top specialty drug pharmacies in the U.S. based on market share 2018
- Definition of specialty drugs by PBMs and pharmacy executives 2011
- Patent applications for genetic drugs worldwide 2010
- Number of approved ANDAs in U.S. 2009-2017
- Pharmaceutical industry: global breakdown in the sale of new drugs 2004-2017
- Average number of ANDAs received per month in U.S. 2009-2017
- Genetic drugs: patent applications worldwide
- Genetic drugs: percentage of patents
- U.S. spending on biosimilars by type 2014
- U.S. spending on multiple sclerosis medicine by type 2010-2014
- Duration of drug development
- Volume of China's drug market 2007-2015
- Industry turnover for leading pharmaceuticals German 2017
- Top global drugs based on revenue in Q2 2012
- Private sector funded drug spending Canada by top drug classes share 2013
- Prescription drug expenditure in the U.S. 1960-2019
- Antimicrobial drugs for livestock exports U.S. 2009-2017
- Drug products patented sales share in Canada, by therapeutic class 2017
- Frequency of drug shortages of individual drugs experienced by hospitals in U.S.
Studies
- Pharmaceutical industry in India
- The Controversey over Rising Drug Prices: The Public's View
- Antibiotic use in the United Kingdom (UK)
- Sobi Anual and sustainability report 2017
- Pharmaceutical industry in Italy
- Overview of Korean Drug Research Association (KDRA), Korea Health Industry Development Ins...
- Pharmaceutical trends in Europe
- Teva - 2018 Form 10-K
- Biotechnology in Germany
- Celgene Corporation - 2018 Form 10-K
- The 2019 Genentech Oncology Trend Report
- The State of Innovation in Highly Prevalent Chronic Diseases 2019
- Biogen Inc. - 2018 Form 10-K
- Gilead Sciences - 2018 Form 10-K
- Boehringer Ingelheim - Annual Report 2018
Statistics on "Eli Lilly"
- Top 10 biotech and pharmaceutical companies based on market cap 2019
- Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- Global biotech prescription drug market share - top 10 companies 2018 and 2024
- Top pharma companies worldwide by number of originated drugs 2019
- Global anti-diabetic revenue by top ten pharmaceutical companies 2017 and 2024
- R&D spending share of top pharmaceutical companies 2018 and 2024
- Eli Lilly's total revenue 2007-2018
- Eli Lilly's total revenue by segment 2014-2018
- Eli Lilly's total revenue by region 2014-2018
- Eli Lilly and Company's top products based on revenue 2014-2018
- Eli Lilly's net income 2007-2018
- Eli Lilly income before income taxes 2013-2018
- Eli Lilly's research and development expenditure 2007-2018
- Eli Lilly: marketing expenses 2013-2018
- Eli Lilly capital expenditures 2013-2018
- Eli Lilly: ad spend in the U.S. 2012-2018
- Eli Lilly employment numbers 2013-2018
- Eli Lilly's total revenue per employee 2013-2018
- Eli Lilly total assets 2013-2018
- Eli Lilly's R&D expenditure as a share of revenue 2010-2018
- Top specialty drug pharmacies in the U.S. by revenue 2018
- Top specialty drug pharmacies in the U.S. based on market share 2018
- Definition of specialty drugs by PBMs and pharmacy executives 2011
- Patent applications for genetic drugs worldwide 2010
- Number of approved ANDAs in U.S. 2009-2017
- Pharmaceutical industry: global breakdown in the sale of new drugs 2004-2017
- Average number of ANDAs received per month in U.S. 2009-2017
- Genetic drugs: patent applications worldwide
- Genetic drugs: percentage of patents
- U.S. spending on biosimilars by type 2014
- U.S. spending on multiple sclerosis medicine by type 2010-2014
- Duration of drug development
- Volume of China's drug market 2007-2015
- Industry turnover for leading pharmaceuticals German 2017
- Top global drugs based on revenue in Q2 2012
- Private sector funded drug spending Canada by top drug classes share 2013
- Prescription drug expenditure in the U.S. 1960-2019
- Antimicrobial drugs for livestock exports U.S. 2009-2017
- Drug products patented sales share in Canada, by therapeutic class 2017
- Frequency of drug shortages of individual drugs experienced by hospitals in U.S.
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.